ZYME
Zymeworks Inc. Common Stock
NASDAQ: ZYME · HEALTHCARE · BIOTECHNOLOGY
$27.83
-0.39% today
Updated 2026-04-29
Market cap
$2.07B
P/E ratio
—
P/S ratio
19.51x
EPS (TTM)
$-1.08
Dividend yield
—
52W range
$11 – $30
Volume
0.7M
Zymeworks Inc. Common Stock (ZYME) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+34.6%
Last 4 quarters
Revenue YoY growth
-91.9%
Most recent quarter
EPS YoY growth
-77.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-8.8%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-02 | $-0.55 | -70.6% | $23.29 | $24.45 | +5.0% |
| 2025-11-06 | $-0.26 | +43.5% | $18.05 | $16.46 | -8.8% |
| 2025-08-07 | $0.03 | +106.5% | $12.41 | $12.02 | -3.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.32 | $-0.55 | -70.6% | $2.52M | -91.9% |
| 2025-09-30 | $-0.46 | $-0.26 | +43.5% | $27.61M | +72.6% |
| 2025-06-30 | $-0.46 | $0.03 | +106.5% | $48.73M | +153.2% |
| 2025-03-31 | $-0.73 | $-0.30 | +58.9% | $27.11M | +170.3% |
| 2024-12-31 | $-0.09 | $-0.31 | -236.2% | $31.03M | +83.3% |
| 2024-09-30 | $-0.41 | $-0.39 | +4.9% | $16.00M | -3.1% |
| 2024-06-30 | $-0.31 | $-0.49 | -58.1% | $19.24M | +174.8% |
| 2024-03-31 | $-0.29 | $-0.42 | -44.8% | $10.03M | -71.8% |
| 2023-12-31 | $-0.43 | $-0.20 | +53.5% | $16.93M | — |
| 2023-09-30 | $-0.47 | $-0.41 | +12.8% | $16.51M | — |
| 2023-06-30 | $-0.47 | $-0.76 | -61.7% | $7.00M | — |
| 2023-03-31 | $-0.54 | $-0.36 | +33.3% | $35.58M | — |
Frequently asked questions
Has Zymeworks Inc. Common Stock beaten earnings estimates?
Zymeworks Inc. Common Stock has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +34.6% over the last 4 quarters.
How does ZYME stock react to earnings?
ZYME stock has moved an average of -2.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Zymeworks Inc. Common Stock's revenue growth rate?
Zymeworks Inc. Common Stock reported year-over-year revenue growth of -91.9% in its most recent quarter, with EPS growing -77.4% year-over-year.